Journals / Üroonkoloji Bülteni / 2016 / Cilt: 15 - Sayı: 3

The Prostatic Urethral Lift Method: A New Minimally Invasive Modality as an Alternative in the Treatment of Benign Prostatic Hyperplasia

Prostatik Üretral Askı Yöntemi: Benign Prostat Hiperplazisi Tedavisinde Yeni Bir Minimal İnvaziv Tedavi Alternatifi

Pages
119–122
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, symptomatic, functional, and sexual outcomes following the prostatic urethral lift procedure were assessed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Improvements in the treatment of benign prostatic hyperplasia (BPH), which is the most common cause of lower urinary tract symptoms in aging males, are proceeding progressively.
📊
Key Findings & Data:The prostatic urethral lift procedure offers a novel treatment option for men with lower urinary tract obstructive symptoms due to BPH.
💡
Conclusion & Impact:In this review, symptomatic, functional, and sexual outcomes following the prostatic urethral lift procedure were assessed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Improvements in the treatment of benign prostatic hyperplasia (BPH), which is the most common cause of lower urinary tract symptoms in aging males, are proceeding progressively. The prostatic urethral lift procedure offers a novel treatment option for men with lower urinary tract obstructive symptoms due to BPH. The prostatic urethral lift can be performed under general, regional and local anesthesia. The procedure shows its effect by retracting the obstructing lobes of the prostate through the capsule to provide a sufficient prostatic urethral opening. It is important to offer an alternative option to the patients who feel anxiety about sexual function loss and complications of the procedure. However, short follow-up period, necessity of suitable conditions, such as lack of median lobe or unremarkable post-voiding residual urine, and lack of cost-effectiveness analysis of the procedure are the limitations of this method. In this review, symptomatic, functional, and sexual outcomes following the prostatic urethral lift procedure were assessed.

Özet

Erkeklerde alt üriner sistem semptomlarının en sık nedeni olan benign prostat hiperplazisinin (BPH) tedavisindeki gelişmeler büyük bir hızla devam etmektedir. Prostatik üretral askı yöntemi BPH'ye bağlı alt üriner semptomları olan erkeklere yeni bir tedavi yöntemi olarak sunulmuştur. Askı yöntemi genel, bölgesel veya lokal anestezi altında uygulanabilmektedir. Yöntem etkisini obstrüksiyon yaratan prostat loblarını implantlarla prostat kapsülüne doğru retrakte edip yeterli prostatik üretra açıklığı sağlayarak gösterir. Tedavi alternatifleri içerisinde özellikle medyan lobu olmayan alt üriner sistem şikayetiyle başvuran cinsel fonksiyon kaybı ve ciddi komplikasyonlar ile ilgili kaygıları olan hastalarda bir seçenek olarak sunulabilmesi açısından önemlidir. Ancak takip sürelerinin kısa olması, uygun hasta seçimi gerekliliği (medyan lobunun olmaması, rezidüel idrar miktarının az olması), maliyet analizlerinin olmaması bu yöntemin kısıtlılıkları olarak göze çarpmaktadır. Bu derlemede, askı yönteminin semptomatik, fonksiyonel ve seksüel sonuçları değerlendirilmiştir.

🔖

Cite This Article

YÜKSEL, A., TEKİN, A. (2016). The Prostatic Urethral Lift Method: A New Minimally Invasive Modality as an Alternative in the Treatment of Benign Prostatic Hyperplasia. Üroonkoloji Bülteni, Cilt: 15 - Sayı: 3, 119–122. https://ajindex.com/articles/334357

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474-479. Lowe FC. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function. BJU Int 2005;95(Suppl 4):12-18.
  2. Hellstrom WJ, Giuliano F, Rosen RC. Ejaculatory dysfunction and its association with lower urinary tract symptomsof benign prostatic hyperplasia and BPH treatment. Urology 2009;74:15-21.
  3. Perera M, Roberts MJ, Doi SA, Bolton D. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta- analysis. Eur Urol 2015;67:704-713.
  4. Larcher A, Broglia L, Lughezzani G, et al. Urethral lift for benign prostatic hyperplasia: a comprehensive review of the literature. Curr Urol Rep 2013;14:620-627. Shore N. A review of the prostatic urethral lift for lower urinary tract symptoms: symptom relief, flow improvement, and preservation of sexual function in men with benign prostatic hyperplasia. Curr Bladder Dysfunct Rep 2015;10:186-192.
  5. Bacmann A, Tubaro A, Barber N, et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study. Eur Urol 2014;65:931-942.
  6. Barkin J, Giddens J, Incze P, et al. Urolift system for relief of prostate obstruction under local anesthesia. Can J Urol 2012;19:6217-6222.
  7. Woo HH, Chin PT, McNicholas TA, et al. Safety anf feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int 2011;108:82-88.
  8. Roehrborn CG, Rukstalis DB, Barkin J, et al. Three year results of the prostatic urethral L.I.F.T study. Can J Urol 2015;22:7772-7782.
  9. Cantwell AL, Bogache WK, Richardson SF, et al. Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int 2014;113:615-622.
  10. Chin PT, Bolton DM, Jack G, et al. Prostatic urethral lift: two year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 2012;79:5-11.
  11. Martin DJ, Mulhall JP. Enlarging the scope of managing benign prostatic hyperplasia: adressing sexual function and quality of life. Int J ClinPr